
WHOLE GENOME ANALYSIS BY ARRAY-BASED
COMPARATIVE GENOMIC HYBRIDIZATION IN
PATIENTS WITH CONGENITAL MALFORMATIONS Dimova I1, Vazharova R1, Nikolova D1, Tincheva R2,
Nesheva D1, Uzunova Y3, Toncheva D1,* *Corresponding Author: Professor Draga Toncheva, Department of Medical Genetics, Medical
University Sofia, 2, Zdrave str., 1431 Sofia, Bulgaria; Tel./Fax: +359-2-952-0357; E-mail:dragatoncheva@yahoo.com page: 33
|
MATERIALS AND METHODS
The study was approved by the Ethics Committee of the Medical University of Sofia, Sofia, Bulgaria. The parents of the children provided their informed consent. Peripheral blood was taken for genetic diagnostic testing. Chromosome Analysis. G-banded chromosomes were prepared from whole blood samples using standard laboratory protocol. DNA Extraction. DNA was extracted from blood samples by phenol-chloroform. The yield and purity for protein/RNA were estimated by a Nanodrop 1000 spectro photometer (Thermo Scientific, Wilmington, DE, USA). The DNA was checked on a 1% agarose gel: DNA of high molecular weight (>50 kb) indicated it was suitable for use. Genomic Arrays. We have used genomic array Cyto Chip (BlueGnome, Cambridge, Cambridgeshire, UK), cov ering the entire genome by bacterial artificial chromosome (BAC) clones at a median 565 kb, a resolution optimized to detect pathogenic imbalances while minimizing polymorphisms. In addition, sub-telomeric clones were included at a median 250 kb resolution, thus allowing reliable detection of mosaicism. The BAC clones of 90 known genetic conditions at a median 100 kb resolution were also included in the chip. This resulted in an average density of 1 clone/0.5 Mb. Probe Labeling, Hybridization, Image Capture and Data Analysis. Test- and sex-matched reference genomic DNA (400 ng) was labeled by random-priming, using a fluorescent labeling system (BlueGnome). The labeled products were puri- fied by AutoSeq™ G50 columns (Amersham Pharmacia Biotech Inc., Piscataway, NY, USA), and the incorporation of dyes was evaluated by the spectrophotometer (Nanodrop 1000, Thermo Scientific). Incorporation in the range of 6-15 pmol/µL and a DNA yield of 180-325 ng/µL were considered suitable for further analysis. A mix of Cy5- and Cy3- labeled probes and a mix of COT-1 and Herring sperm DNA were ethanol-precipitated at –80°C for at least 30 min. Hybridization was done using dissolved precipitated probes in a hybridization buffer.Arrays were washed in sodium chloride-sodium citrate (SSC) buffers with decreasing concentrations and scanned by a GenPix 4100A (Axon Instruments, Union City, CA, USA). The images were analyzed by BlueFuse for Microarrays 3.5 software (BlueGnome). In data processing log2 ratios of Cy3 and Cy5, intensities were generated for all hybridized clones. Normal copy numbers were considered to be present if the log2 ratio was between –0.3 and +0.3, values above +0.3 were interpreted as gain/ amplification and those under –0.3 as losses (deletions). Genomic profiles were represented plotting log2 ratios in Y-axis and the 23 chromosomes in Xaxis. Individual chromosomal profiles were represented with clone positions in Y-axis and log2 ratios in X-axis.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|